Market Tracker

07/29 5:16pm ET

Galena Biopharma Inc (NASDAQ:GALE)

0.4446
Delayed Data
As of Jul 29
 -0.0254 / -5.40%
Today’s Change
0.28
Today|||52-Week Range
2.49
-69.76%
Year-to-Date
Aetna (AET) Poised to Beat on Earnings in Q2: Here's Why
Jul 29 / Zacks.com - Paid Partner Content
Galena Biopharma (GALE) is Oversold: Can It Recover?
Jul 20 / Zacks.com - Paid Partner Content
Flowserve (FLS) Q2 Earnings: What's in Store for the Stock?
Jul 26 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close0.47
Today’s open0.45
Day’s range0.44 - 0.47
Volume5,000,110
Average volume (3 months)6,441,544
Market cap$97.1M
Dividend yield--
Data as of 3:59pm ET, 07/29/2016

Growth & Valuation

Earnings growth (last year)-23.32%
Earnings growth (this year)+43.29%
Earnings growth (next 5 years)--
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book5.54

Competitors

 Today’s
change
Today’s
% change
OCXOncoCyte Corp-0.10-2.58%
MRTXMirati Therapeutics ...+0.08+1.75%
CTICCTi Biopharma Corp+0.01+1.70%
REPHRecro Pharma Inc0.000.00%
Data as of 4:01pm ET, 07/29/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$0.00
Annual profit (last year)-$59.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark W. Schwartz
Senior VP-Clinical Sciences &
Operations
Gavin S. Choy
Corporate headquarters
San Ramon, California

Forecasts